The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(5-((2,4-diaminopyrimidin-5-yl)methyl)-2,3-dimethoxyphenyl)pent-4-ynoic acid ID: ALA2282813
PubChem CID: 76312739
Max Phase: Preclinical
Molecular Formula: C18H20N4O4
Molecular Weight: 356.38
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(Cc2cnc(N)nc2N)cc(C#CCCC(=O)O)c1OC
Standard InChI: InChI=1S/C18H20N4O4/c1-25-14-9-11(8-13-10-21-18(20)22-17(13)19)7-12(16(14)26-2)5-3-4-6-15(23)24/h7,9-10H,4,6,8H2,1-2H3,(H,23,24)(H4,19,20,21,22)
Standard InChI Key: NTEDBEJGQHMAKR-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 27 0 0 0 0 0 0 0 0999 V2000
11.7585 -2.5052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4662 -2.0966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1739 -2.5052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0512 -2.0937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3440 -2.5016 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.3436 -3.3197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0562 -3.7281 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.7605 -3.3179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1714 -3.3235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8782 -3.7320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5869 -3.3234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5843 -2.5019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8768 -2.0971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0528 -1.2765 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.6364 -3.7292 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.2906 -2.0908 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.9997 -2.4969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2952 -3.7310 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.2963 -4.5482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8778 -4.5492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8716 -5.3654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8654 -6.1826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5700 -6.5965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2808 -6.1934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9853 -6.6073 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.2870 -5.3762 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
1 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 1 1 0
3 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 3 1 0
4 14 1 0
6 15 1 0
12 16 1 0
16 17 1 0
11 18 1 0
18 19 1 0
10 20 1 0
20 21 3 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
24 26 2 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 356.38Molecular Weight (Monoisotopic): 356.1485AlogP: 1.47#Rotatable Bonds: 6Polar Surface Area: 133.58Molecular Species: ACIDHBA: 7HBD: 3#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 5#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.60CX Basic pKa: 8.16CX LogP: 0.30CX LogD: -0.13Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.66Np Likeness Score: 0.18
References 1. Kiani YS, Kalsoom S, Riaz N. (2013) In silico ligand-based pharmacophore model generation for the identification of novel Pneumocystis carinii DHFR inhibitors, 22 (2): [10.1007/s00044-012-0082-2 ]